entertainment -WSS

entertainment

author：entertainment 2025-09-30 00:51:20 - browse：2943

An AstraZeneca sign at ESMO in Madrid. — An AstraZeneca ad at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months.

On Monday, data presented here from a trial of the drug in advanced non-small cell lung cancer provided at least a fuller look. While the results assuaged some of the safety fears that flared when initial information was released over the summer, they only heightened concerns about the drug’s ability to outperform standard chemotherapy — though they perhaps pointed to an opportunity for the drug in a subset of patients.

The trial, detailed here in a prime session at the annual meeting of the European Society for Medical Oncology, is testing a therapy called datopotamab deruxtecan, or Dato-DXd, in advanced or metastatic non-small cell lung cancer in patients who already tried at least first-line treatments. Patients were randomized to either receive chemotherapy or Dato-DXd, which AstraZeneca is developing with Daiichi Sankyo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Change Healthcare cyberattack shows risk of industry consolidation

knowledge

leisure time

WSS

Readout Newsletter: Beam, Prozac, "TechBio" and more

Ohio train derailment: Experts on toxic chemical risks

Virtual repurposing can help discover new uses for existing drugs

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Create a giant ice tray with this foil pan hack to keep food cold this summer

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

entertainment

entertainment

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

5 ways to address the shortage of health care workers

The high cost of giving birth even with insurance

Childhood vaccination ad campaign launches in the U.K.

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Sports medicine is finally prioritizing gender equality

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Hollywood unions extend contract negotiations for actors

Change Healthcare cyberattack shows risk of industry consolidation

leisure time

Biden’s NIH nominee is languishing in Congress

Biden’s NIH nominee is languishing in Congress

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Using force crossed my mind when examining a defiant young patient

Pfizer is about to make a big push in cancer. Will investors listen?

knowledge

hotspot

leisure time

focus